G26-42434-19909
2 vaccinations
16 coded responses
24 check-ins
16 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 403 / KY
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
-
2020-12-17
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Chills, Fatigue or tirednessFree text: Swollen lymph nodes in neck on side of injextionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-18
Survey response — days 1–6 daily, dose 1MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, SwellingFree text: Swollen and tender cervical lymph nodes.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-19
Survey response — days 1–6 daily, dose 1MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Cervical lymph node swelling and tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Improving lymphadenopathy in neck.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild no tender cervical lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Persistent cervical lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-23
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Persistent cervical lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Survey response — day 14, dose 1MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Persistent cervical lymphadenopathy. Has not changed in size or tenderness since the vaccination.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Survey response — day 0, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Persistent cervical lymphadenopathy since day of first vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: Persistent cervical nodes since first shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Persistent cervical nodes on the left from first vaccine and large tender nodes in the right axillary area as well as cervical area on the right since last night.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Continued lymphadenopathy bilateral cervical and right axillary nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Persistent cervical and axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Persistent cervical and axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Persistent cervical and axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Persistent cervical lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-17
- 2021-04-07
- 2021-07-07
- 2022-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen lymph nodes in neck on side of injextion
Systemic reaction (other): Swollen and tender cervical lymph nodes.
Systemic reaction (other): Cervical lymph node swelling and tenderness
Systemic reaction (other): Improving lymphadenopathy in neck.
Systemic reaction (other): Mild no tender cervical lymphadenopathy
Systemic reaction (other): Persistent cervical lymphadenopathy
Release 1 — day 7, dose 1
Systemic reaction (other): Persistent cervical lymphadenopathy
Release 1 — day 14, dose 1
Symptoms: Persistent cervical lymphadenopathy. Has not changed in size or tenderness since the vaccination.
Release 1 — day 0, dose 2
Systemic reaction (other): Persistent cervical lymphadenopathy since day of first vaccine
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Persistent cervical nodes since first shot.
Systemic reaction (other): Persistent cervical nodes on the left from first vaccine and large tender nodes in the right axillary area as well as cervical area on the right since last night.
Systemic reaction (other): Continued lymphadenopathy bilateral cervical and right axillary nodes
Systemic reaction (other): Persistent cervical and axillary lymphadenopathy
Systemic reaction (other): Persistent cervical and axillary lymphadenopathy
Systemic reaction (other): Persistent cervical and axillary lymphadenopathy
Release 2 — day 7, dose 2
Systemic reaction (other): Persistent cervical lymphadenopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lymph node pain | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Tenderness | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release